Substantial savings opportunities exist by using lower-cost biologics for patients with plaque psoriasis, according to one ...

Sanofi’s development of an oral spin on Humira’s mechanism has hit a setback. | Sanofi’s development of an oral spin on ...

In this article we will help you to know more about the infusion therapy, about its process, precautions to be taken care ...

Low-grade systemic inflammation is an independent risk factor for psoriasis, especially moderate to severe disease, results ...

China’s National Medical Products Administration has given the thumbs up to Akeso Pharmaceuticals Inc.’s ebdarokimab for treating moderate to severe plaque psoriasis in adults. An interleukin ...

GLP-1s exploded seemingly out of nowhere, straining pharmacy plan bottom lines. Psoriasis treatments don't have to follow the ...

While previous treatment approaches have mainly focused on inhibiting pro-inflammatory immune cells ... Drug to Fight Psoriasis Feb. 3, 2025 — Psoriasis is a chronic skin disease that manifests ...

Discover the signs of psoriatic arthritis, from joint pain and skin changes to nail damage and fatigue, plus the latest treatment options for this condition.

Discover 5 insights about psoriatic arthritis from rheumatology experts, including pain management strategies, treatment ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Having psoriasis raises your risk of psoriatic arthritis — and rheumatoid arthritis, too. Make sure you can tell these two forms of arthritis apart.